Holen Sie sich die Stockscreener-App
51.09
2.09%
-1.09
Enliven Therapeutics Inc Aktie (ELVN) Neueste Nachrichten
Enliven Therapeutics, Inc. (ELVN) Upgraded to Buy: Here's What You Should Know - MSN
H.C. Wainwright Maintains Enliven Therapeutics(ELVN.US) With Buy Rating, Raises Target Price to $64 - Moomoo
Enliven Therapeutics Is Maintained at Buy by HC Wainwright & Co. - Moomoo
H.C. Wainwright raises Enliven Therapeutics price target on trial data By Investing.com - Investing.com Canada
ELVN Maintained by HC Wainwright & Co. -- Price Target Raised to $64 - GuruFocus
Insider Sell Alert: Lori Kunkel Sells 10,000 Shares of Enliven T - GuruFocus
Enliven Therapeutics (ELVN) Fell Out Of Russell Indexes, But Is The Valuation Already Rich? - simplywall.st
Enliven Therapeutics Insider Sold Shares Worth $504,903, According to a Recent SEC Filing - marketscreener.com
Enliven Therapeutics (ELVN) director sells 10,000 shares under 10b5-1 plan - Stock Titan
Enliven Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares - AOL.com
How Enliven Therapeutics Inc. (ELVN) Affects Rotational Strategy Timing - Stock Traders Daily
Enliven Therapeutics stock hits 52-week high at $40.66 - Investing.com
Enliven Therapeutics (ELVN) Stock Looks Overvalued As Returns Surge But Book Value Lags - Yahoo Finance
ELVN Maintained by Stifel -- Price Target Raised to $80 - GuruFocus
Stifel Maintains Enliven Therapeutics(ELVN.US) With Buy Rating, Raises Target Price to $80 - Moomoo
Medical Hedge Fund Sells 281,000 Shares of Enliven Theapeutics. Is it Time to Sell ELVN? - AOL.com
ELVN Maintained by Jones Trading -- Price Target Raised to $70.0 - GuruFocus
Jones Trading raises Enliven Therapeutics price target on CML trials By Investing.com - Investing.com South Africa
JonesTrading Maintains Enliven Therapeutics(ELVN.US) With Buy Rating, Raises Target Price to $70 - Moomoo
Enliven Therapeutics, Inc.(NasdaqGS:ELVN) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
Jones Trading raises Enliven Therapeutics price target on CML trials - Investing.com
Enliven Therapeutics, Inc.(NasdaqGS:ELVN) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Enliven Therapeutics, Inc.(NasdaqGS: ELVN) dropped from Russell Microcap Index - marketscreener.com
Enliven Therapeutics, Inc.(NasdaqGS: ELVN) dropped from Russell 3000E Index - marketscreener.com
What to Know About This $345,000 Enliven Insider Sale as the Stock Soars 130% - Yahoo Finance
What to Know About OrbiMed's $39 Million Enliven Therapeutics Stock Sale Amid a 130% Rally - AOL.com
What to Know About OrbiMed's $39 Million Enliven Therapeutics Stock Sale Amid a 130% Rally - The Motley Fool
Enliven Therapeutics, Inc. Actuals & Estimates (NASDAQ:ELVN) - TradingView
ELVN Forecast — Price Target — Prediction for 2027 - TradingView
(ELVN) and the Role of Price-Sensitive Allocations - Stock Traders Daily
22% Below Analyst Target, Is Enliven Therapeutics (ELVN) Fairly Valued Here - Sahm
OrbiMed entities sell $39 million in Enliven Therapeutics stock By Investing.com - Investing.com Nigeria
Enliven Therapeutics(ELVN.US) 10% Shareholder Sells US$39.01 Million in Common Stock - Moomoo
Form 4 Enliven Therapeutics Inc For: 24 June By Investing.com - Investing.com South Africa
OrbiMed entities sell $39 million in Enliven Therapeutics stock - Investing.com UK
Form 13D/A Enliven Therapeutics For: 24 June By Investing.com - Investing.com South Africa
OrbiMed funds trim Enliven Therapeutics (NASDAQ: ELVN) stake with 860K-share sale - Stock Titan
OrbiMed cuts Enliven Therapeutics (ELVN) holdings to 9.5% of shares - Stock Titan
ETFs Investing in Enliven Therapeutics, Inc. Stocks - TradingView
Enliven Therapeutics stock hits 52-week high at 48.55 USD By Investing.com - Investing.com India
Enliven Therapeutics stock hits 52-week high at 48.55 USD - Investing.com UK
2.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):